Four Ways to Go Public—and What Each One Really Buys You

People tend to use "IPO" and "going public" interchangeably. But an IPO is really just one of four basic ways a private company can reach the public markets.

That is a little like using "mortgage" and "buying a house" interchangeably. The mortgage is one way to finance the thing. It is not the thing.

The four routes — a traditional IPO, a direct listing, a reverse merger, and a SPAC — trade off three things that matter enormously: capital, cost, and complexity. The mistake is starting with How do we get public? before answering What do we need the transaction to do?

The regular way: a traditional IPO

This is the familiar route. You hire the banks, go through the roadshow and book-building process, issue new shares, and raise primary capital.

Capital: This is where the traditional IPO shines. The company sells newly issued shares to investors and puts the proceeds on its balance sheet. For a business with the scale, story, and institutional demand to support it, no other route offers quite the same conventional capital-raising machinery.

Cost: It is also expensive. Underwriting fees alone commonly land in the mid-single digits as a percentage of gross proceeds, before legal, accounting, exchange, and public-company-readiness costs. Management also pays in time, distraction, and a great many meetings that could have been emails.

The IPO is demanding because it is trying to do several jobs at once: raise capital, establish a market, distribute shares, and introduce the company to public investors.

The elegant way: a direct listing

A direct listing basically says: we do not necessarily need the traditional IPO machinery; we need a public market for our shares.

Capital: Historically, none. Existing shareholders could sell, but the company did not issue new shares for cash. That has changed. Exchange rules now permit a direct listing with a primary capital raise, although the structure is still far less established than a traditional IPO and is not a magic way to eliminate the banks.

Cost: You can avoid the classic underwriting structure in a conventional direct listing, but you do not avoid the cost of becoming public. You still need lawyers, accountants, SEC registration, exchange approval, investor education, and systems capable of surviving quarterly reporting.

The best candidates usually have substantial name recognition, sophisticated existing shareholders, and real market demand before the opening trade. Not every company has a market waiting for its stock. Most do not.

The inherited way: a reverse merger

Then there is the old-fashioned reverse merger: put the private operating company into an existing public shell.

In theory, simple. In practice, the operative word is clean.

Capital: Usually, you are bringing your own. The shell itself is not inherently a capital raise, so the transaction is often paired with a PIPE or another private financing.

Cost: Potentially lower upfront than a traditional IPO, but much harder to generalize. You are paying for the shell, the transaction, and the financing — and possibly for problems you did not create.

What is hiding in the cap table? Are there legacy shareholders, liabilities, bad filings, litigation, or other surprises? A cheap shell can get expensive quickly. With a reverse merger, the quality of the shell may matter as much as its price.

The negotiated way: a SPAC

A SPAC can offer a cleaner vehicle than an old shell and a more negotiated path than a traditional IPO. It can also bring meaningful capital.

But! Of course there is a but.

Capital: The cash is not simply whatever the SPAC raised in its own IPO. It is whatever remains in trust after shareholder redemptions, plus any PIPE or other financing raised alongside the deal. Potentially substantial, yes. Guaranteed, no.

Cost: Legal and advisory fees are only part of the bill. Sponsor economics, warrants, PIPE terms, redemptions, and dilution all matter. That is why saying a SPAC is simply "cheaper than an IPO" is usually wrong, or at least incomplete enough to be dangerous.

A SPAC is a tool. Sometimes a very good one. Structure, valuation, incentives, and execution determine whether it remains one.

What are you actually optimizing for?

Here is the short version:

• Traditional IPO: strongest conventional capital raise; highest cost and a demanding process.
• Direct listing: elegant and less intermediated in its classic form; best suited to a company that already has recognition, holders, and demand.
• Reverse merger: potentially faster and cheaper upfront; inherits someone else's public vehicle, warts and all, and usually needs separate financing.
• SPAC: negotiated and capable of bringing substantial capital; vulnerable to redemptions and economic costs that hide outside the fee line.

There is no universally best route. There is only a best route for a particular company, in a particular market, with a particular balance sheet.

The question I keep coming back to is not simply:

How do we get this company public?

It is:

Which path gives this company the best chance of being a successful public company once it gets there?

The second question is a lot more important.